Cargando…

Mismatch negativity generation in the human 5HT(2A) agonist and NMDA antagonist model of psychosis

RATIONALE: Many studies have reported deficits of mismatch negativity (MMN) in schizophrenic patients. Pharmacological challenges with hallucinogens in healthy humans are used as models for psychotic states. Previous studies reported a significant reduction of MMN after ketamine (N-methyl-d-aspartat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heekeren, Karsten, Daumann, Jörg, Neukirch, Anna, Stock, Carsten, Kawohl, Wolfram, Norra, Christine, Waberski, Till D., Gouzoulis-Mayfrank, Euphrosyne
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2008
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668652/ https://www.ncbi.nlm.nih.gov/pubmed/18488201 http://dx.doi.org/10.1007/s00213-008-1129-4

Ejemplares similares

Correlation of passivity symptoms and dysfunctional visuomotor action monitoring in psychosis
por: Schnell, Knut, et al.
Publicado: (2008)

Neurotoxicity of drugs of abuse - the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines
por: Gouzoulis-Mayfrank, Euphrosyne, et al.
Publicado: (2009)

Learning, Memory, and Executive Function in New MDMA Users: A 2-Year Follow-Up Study
por: Wagner, Daniel, et al.
Publicado: (2015)

Utilization of Inpatient Mental Health Care in the Rhineland During the COVID-19 Pandemic
por: Zielasek, Jürgen, et al.
Publicado: (2021)

Mismatch negativity generation in subjects at risk for psychosis: source analysis is more sensitive than surface electrodes in risk prediction
por: Aeberli, Tina, et al.
Publicado: (2023)

Adapting and Implementing Apps for Mental Healthcare
por: Zielasek, Jürgen, et al.
Publicado: (2022)

Analysis of the utilization, processes, and outcomes of inpatient mental healthcare during the first three waves of the COVID-19 pandemic in the federal state of North Rhine-Westphalia, Germany
por: Zielasek, Jürgen, et al.
Publicado: (2022)

Determinants of compulsory hospitalisation at admission and in the course of inpatient treatment in people with mental disorders—a retrospective analysis of health records of the four psychiatric hospitals of the city of Cologne
por: Peters, Sönke Johann, et al.
Publicado: (2022)

Early Somatosensory Processing Over Time in Individuals at Risk to Develop Psychosis
por: Hagenmuller, Florence, et al.
Publicado: (2019)

A retrospective analysis of determinants of involuntary psychiatric in-patient treatment
por: Schmitz-Buhl, Mario, et al.
Publicado: (2019)

Homelessness among psychiatric inpatients in North Rhine-Westphalia: a retrospective routine data analysis
por: Haussleiter, Ida Sibylle, et al.
Publicado: (2022)

Early Recognition of High Risk of Bipolar Disorder and Psychosis: An Overview of the ZInEP “Early Recognition” Study
por: Theodoridou, Anastasia, et al.
Publicado: (2014)

Frontal brain activity in individuals at risk for schizophrenic psychosis and bipolar disorder during the emotional Stroop task – an fNIRS study
por: Aleksandrowicz, Aleksandra, et al.
Publicado: (2020)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

Early somatosensory processing in individuals at risk for developing psychoses
por: Hagenmuller, Florence, et al.
Publicado: (2014)

The effect of NMDA-R antagonist, MK-801, on neuronal mismatch along the rat auditory thalamocortical pathway
por: Parras, Gloria G., et al.
Publicado: (2020)

The somatic care of patients with comorbid mental disorders: protocol of a mixed-methods study aiming to identify barriers to and enablers of utilization of somatic healthcare (SoKo)
por: Groß, Sophie E., et al.
Publicado: (2023)

CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
por: Capi, Matilde, et al.
Publicado: (2021)

Psychiatric Acute Day Hospital as an Alternative to Inpatient Treatment
por: Heekeren, Karsten, et al.
Publicado: (2020)

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013)

NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans
por: de la Salle, Sara, et al.
Publicado: (2019)

NMDA Receptor Antagonists for Treatment of Depression
por: Ates-Alagoz, Zeynep, et al.
Publicado: (2013)

Region-Specific Enhancement of c-fos Expression by Combined Treatment With NMDA Receptor Agonists and Antagonists With Antidepressant Potential
por: Vasilescu, Andrei-Nicolae, et al.
Publicado: (2022)

Identification of risk factors for involuntary psychiatric hospitalization: using environmental socioeconomic data and methods of machine learning to improve prediction
por: Karasch, O., et al.
Publicado: (2020)

Allosteric antagonist action at triheteromeric NMDA receptors
por: Gibb, Alasdair J.
Publicado: (2022)

Effects of (−)‐MBP, a novel 5‐HT(2C) agonist and 5‐HT(2A/2B) antagonist/inverse agonist on brain activity: A phMRI study on awake mice
por: Sathe, Preeti K., et al.
Publicado: (2023)

From Formative Research to Cultural Adaptation of a Face-to-Face and Internet-Based Cognitive-Behavioural Intervention for Arabic-Speaking Refugees in Germany
por: Böttche, Maria, et al.
Publicado: (2021)

The 5-HT(2C) receptor agonist, lorcaserin, and the 5-HT(6) receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour
por: Higgs, Suzanne, et al.
Publicado: (2015)

Alteration of NMDA receptor trafficking as a cellular hallmark of psychosis
por: Espana, Agnès, et al.
Publicado: (2021)

Contributions of Experimental Psychiatry to Research on the Psychosis Prodrome
por: Bodatsch, Mitja, et al.
Publicado: (2013)

Mechanical stress activates NMDA receptors in the absence of agonists
por: Maneshi, Mohammad Mehdi, et al.
Publicado: (2017)

Does mismatch negativity have utility for NMDA receptor drug development in depression?
por: Murphy, Nicholas, et al.
Publicado: (2021)

Interactions of a Dopamine D(1) Receptor Agonist with Glutamate NMDA Receptor Antagonists on the Volitional Consumption of Ethanol by the mHEP Rat
por: McMillen, Brian A., et al.
Publicado: (2013)

Forecasting prognostic trajectories with mismatch negativity in early psychosis
por: Kim, Minah, et al.
Publicado: (2023)

The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT(3) receptors
por: Lochner, Martin, et al.
Publicado: (2016)

Holographic Quantitative Structure-Activity Relationships of Tryptamine Derivatives at NMDA, 5HT(1A) and 5HT(2A) Receptors
por: Palangsuntikul, Rungtiva, et al.
Publicado: (2013)

NMDA Receptor Encephalitis with Concurrent Autoimmune Hypophysitis Presented with Acute Psychosis
por: Lopimpisuth, Chawit, et al.
Publicado: (2020)

Considerations of psychotic symptomatology in anti‐NMDA encephalitis: Similarity to cycloid psychosis
por: Giné Servén, Eloi, et al.
Publicado: (2019)

Anti-NMDA receptor encephalitis and psychosis: case report and literature review
por: Gutierrez Higueras, T., et al.
Publicado: (2022)

Investigation of anti-NMDA receptor antibodies in first episode psychosis patients
por: Zsigmond, R.I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m84qa9v330b70ntphupnru6q36